DTC Genetic Testing Market Size (2024 – 2030)

As per recent market analysis, the Global Direct-to-Consumer (DTC) Genetic Testing Market recorded a value of $1.13 billion in 2023, with an anticipated growth to $3.01 billion by the end of 2030. This growth trajectory suggests a Compound Annual Growth Rate (CAGR) of 15% over the forecast period spanning from 2024 to 2030.

Industry Overview

The landscape of the DTC genetic testing sector is characterized by a diverse array of players, encompassing established entities alongside emerging startups. Notably, numerous startups are emerging, offering superior DTC genetic tests at competitive prices, thus addressing concerns related to affordability and fostering market expansion. DTC genetic testing entails the direct provision of genetic information to consumers, circumventing the involvement of medical professionals or health insurance entities. This approach enables consumers to submit their DNA samples directly to companies and receive prompt results. The accessibility, affordability, and expediency of DTC genetic testing contribute to its burgeoning popularity. Moreover, this mode of testing facilitates awareness regarding various genetic conditions, aids in health prognostication, and furnishes insights into ancestry and common traits, among other benefits. Such favorable dynamics are poised to fuel the growth of the market in the foreseeable future.

Market Growth Drivers

The market will expand due to rising demand for customized direct-to-consumer genetic testing services

The proliferation of DTC genetic testing is propelled by heightened public awareness across both developed and emerging economies. Key industry players are channeling efforts towards the development of high-quality DTC genetic testing solutions, ensuring accurate and reliable results. Notably, initiatives such as the promotion of DTC genetic testing by renowned companies like 23andMe through retail pharmacies and online platforms, accompanied by attractive promotional schemes, contribute to market expansion.

Increased use of genetic data in the healthcare industry will help propel the market forward

Furthermore, the uptick in disposable incomes in emerging economies is anticipated to underpin the growth of the DTC genetic testing industry. However, the upward trajectory of DTC genetic testing costs may pose a constraint on market expansion in the short term. Additionally, the evolving demand for customized services presents opportunities for market growth in the ensuing years, notwithstanding potential challenges associated with product deficiencies.

Impact of Covid-19 on the Industry

The COVID-19 pandemic has catalyzed demand for DTC genetic testing, driven by technological advancements and evolving consumer preferences amidst the crisis. Notably, the surge in chronic illnesses and the introduction of tailored testing kits tailored to specific therapeutic domains have bolstered the adoption of DTC genetic testing. The availability of these kits through online platforms further augments market dynamics, contributing positively to market statistics.

Market Restraints

This type of testing cannot tell definitively whether you will or will not get a particular disease

Despite its advantages, DTC genetic testing may not definitively ascertain an individual's susceptibility to particular diseases. Often, such testing provides limited insights into disease predisposition, owing to its focus on a select set of genetic variations associated with specific phenotypes. The multifactorial nature of diseases, influenced by genetic, environmental, and lifestyle factors, underscores the inherent limitations of DTC genetic testing in predicting disease onset accurately.

Global DTC Genetic Testing Market- By Test Type

• Carrier Testing
• Predictive Testing
• Ancestry & Relationship Testing
• Nutrigenomic Testing
• Skincare Testing

The Global Direct-to-Consumer (DTC) Genetic Testing Market, categorized by test type, encompasses various tests such as Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomic Testing, and Skincare Testing. In 2021, the Ancestry & Relationship Testing segment dominated the market with over 40% market share. This growth is attributed to the decreasing costs of genetic ancestry tests, particularly benefiting from heightened demand in developed nations like the United States. Ancestry testing, also referred to as genetic genealogy, facilitates individuals in exploring their familial lineage through historical data, analyzing DNA variations among individuals with similar backgrounds. For instance, FamilyTreeDNA offers Familial Finder DNA testing to uncover familial connections and ancestral ties, leveraging DNA comparisons with archaeological excavation sites. Consequently, there's a surging demand for ancestry and relationship testing, which is expected to propel market growth.

Global DTC Genetic Testing Market- By Technology

• Targeted analysis
• Single nucleotide polymorphism (SNP) chips
• Whole Genome Sequencing (WGS)

Regarding technology, the DTC genetic testing market is segmented into Whole Genome Sequencing (WGS), Targeted Analysis, and Single Nucleotide Polymorphism (SNP) chips. In 2021, the Whole Genome Sequencing sector generated approximately USD 212 million in revenue. Whole Genome Sequencing enables comprehensive genomic analysis, aiding in identifying chromosomal regions linked to genetic influences on various phenotypes. It captures both minor and major variants, identifies causative variants, and provides extensive data promptly. The technology finds applications in detecting diverse disorders, pharmacogenomics, family hereditary diseases, and atypical tumor forms, fostering the demand for Whole Genome Sequencing technology and influencing market trends positively.

Global DTC Genetic Testing Market- By Distribution Channel

• Online Platform
• Over the counter

Distribution channels in the DTC genetic testing market comprise online platforms and over-the-counter testing. The online platforms segment is anticipated to witness a CAGR of about 15.5% through 2028, propelled by increased healthcare app usage and expanding internet accessibility. These platforms offer a wide array of product offerings, facilitating convenient business transactions and enabling companies to reach a global clientele, thereby fostering market growth.

Global DTC Genetic Testing Market- By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

Geographically, the market spans regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. In 2021, North America dominated with a market share exceeding 39%, poised for substantial growth in subsequent years. The surge is attributed to heightened awareness of DTC genetic testing in the United States and Canada, supported by increased internet penetration in densely populated areas. Additionally, simplified regulatory procedures across the region, such as those by the Food and Drug Administration, contribute to market expansion by streamlining test validation processes, further stimulating consumer demand.

Global DTC Genetic Testing Market- By Companies

1. 23andMe, Inc.
2. Ancestry.com, LLC
3. Any Lab Test Now
4. Color Health, Inc.
5. Direct Laboratory Services, LLC
6. DNA Diagnostics Center
7. Easy DNA
8. Full Genomes Corporation, Inc.
9. Gene by Gene, Ltd.
10. Genesis Healthcare
11. Helix OpCo LLC
12. Laboratory Corporation of America® Holdings

These players employ various growth strategies, including continuous innovations and technological advancements, to maintain market competitiveness.

NOTABLE HAPPENINGS IN THE GLOBAL DIGITAL FREIGHT SHIPPING MARKET IN THE RECENT PAST:

• Merger & Acquisition: - In November 2021, 23andme announced the closing of its acquisition of Lemonaid Health.
• Merger & Acquisition: - In February 2021, 23andMe going public at $3.5B via a merger with Branson's blank check company.